We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Agilent Technologies and Lipomics Collaborate

By Labmedica staff writers
Posted on 20 Feb 2007
Agilent Technologies Inc., (Santa Clara, CA, USA) and Lipomics Technologies Inc., (West Sacramento, CA, USA) will collaborate to develop diagnostic and research assays combining Agilent analytic platforms with Lipomics' expertise in biomarker discovery and validation.

The assays will focus on metabolic diseases, a family of related disorders driven in large part by subtle, long-term dysregulation of lipid metabolism. More...
Lipomics Technologies provides quantitative, diagnostically accurate measurements of more than 1,500 metabolites, allowing comprehensive profiling of whole-body lipid metabolism. The company's quantitative methods and expertise in lipid biology drive development of clinically relevant diagnostic and research assays. A wide range of Agilent liquid and gas chromatography, hyphenated technique instrumentation, reagents, microarrays, and informatics software will be deployed as needed.

Lipomics has developed considerable expertise in investigating the role that lipid metabolism plays in disease mechanisms, said Michael McNulty, general manager of Diagnostics, Agilent Life Sciences and Chemical Analysis. Both companies see significant synergies in combining this expertise with Agilent's capabilities to separate, detect, and analyze molecules in the development of new diagnostic tools.

We look forward to building clinically relevant diagnostic products together, said Meeta Patnaik, chief medical officer, Lipomics. Lipid diagnostics are [the] key to managing patients in areas such as cardiovascular risk, CNS disorders and inflammation, and requires the combination of well validated biomarkers and high-throughput technology for commercialization. The Agilent 2100 Bioanalyzer is [the] key to the collaboration, as the microfluidic-based lab-on-a-chip system delivers the analytic performance, automation, and low sample consumption required to study metabolic biomarkers.

Lipomics Technologies provides metabolic assessments for clinical diagnostics, personalized medicine, and drug research. The company's analytic technologies generate comprehensive, accurate, and quantitative profiles of lipid metabolites.

Agilent's bio-analytic measurement business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify, and analyze the physical and biologic properties of substances and products.




Related Links:
Agilent
Lipomics

Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Hematology System
Medonic M16C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Size assessment of patient-derived material from various tauopathies (Aragonès Pedrola J. et al., PNAS (2025); DOI: 10.1073/pnas.2502847122)

First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection

The disease process in Alzheimer’s begins long before memory loss or cognitive decline becomes apparent. During this silent phase, misfolded proteins gradually form amyloid fibrils, which accumulate in... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.